Form 4: Arteris CFO Sells Shares Under Pre-Arranged Trading Plan

Arteris, Inc.'s VP and Chief Financial Officer, Nicholas B. Hawkins, sold a total of 2,451 shares of common stock in early June 2025, pursuant to a Rule 10b5-1 trading plan.

Summary

• Nicholas B. Hawkins, the Vice President and Chief Financial Officer of Arteris, Inc. (AIP), reported two separate sales of the company's common stock.
• On June 4, 2025, Mr. Hawkins sold 1,730 shares of common stock at a weighted average price of $8.0214 per share. The sales occurred within a price range of $8.00 to $8.05.
• On June 5, 2025, an additional 721 shares of common stock were sold at a weighted average price of $7.6575 per share. These sales took place within a price range of $7.60 to $7.74.
• Both transactions were executed under a Rule 10b5-1 trading plan, which was adopted by Mr. Hawkins on May 20, 2024.
• Following these reported transactions, Mr. Hawkins' direct beneficial ownership of Arteris common stock stands at 165,707 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can sometimes be perceived negatively, these sales were conducted under a pre-arranged 10b5-1 trading plan, which is a common practice for corporate insiders to manage their stock holdings and does not necessarily reflect a negative view of the company's prospects.

Positives

• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which indicates the sales were scheduled in advance and not based on immediate, non-public information, often viewed as a positive for corporate governance and transparency.

Negatives

• The sales represent a reduction in insider ownership, which can sometimes be perceived negatively by investors, even if pre-planned.
• The weighted average sale price for the second transaction ($7.6575) was lower than the first ($8.0214), indicating a slight decline in the stock price during the period of sales.

Future Outlook

This document is a Form 4 filing, which reports historical insider transactions and does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing details routine insider stock sales for Arteris, Inc.'s CFO. It does not provide information on broader industry trends or competitive landscape, as its sole purpose is to report changes in beneficial ownership.

Stakeholder Impact

• Shareholders: May observe a reduction in insider ownership, but the pre-planned nature of the sales under a 10b5-1 plan typically mitigates concerns about management's confidence in the company.

Key Dates

Keywords

Arteris Inc., AIP, Form 4, Insider Trading, Stock Sale, Nicholas B. Hawkins, 10b5-1 Plan, Beneficial Ownership, CFO